Dr. Reddy's Laboratories, Inc v. Celgene Corporation > Summary
Court Case Number IPR2018-01507
Filing Date Aug 3, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesGrace Karaffa Obermann, Tina E. Hulse, Christopher G. Paulraj
Judge Writing the Final DecisionGrace Karaffa Obermann
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Petitioner
Patent Owner
Petitioner Attorneys
4Dr. Reddy's Laboratories
Attorney Name: Brandon M. White
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Emily J. Greb
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Crystal R. Canterbury
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Marc R. Levin
Perkins Coie
Patent Owner Attorneys
8Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Christopher J. Harnett
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: John Elsevier
Celgene
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08404717 | Methods of treating myelodysplastic syndromes using lenalidomide | Mar 26, 2013 |
